File #: Int 0620-2024    Version: * Name: The development by the commissioner of health and mental hygiene of materials on the consequences of off-label use for weight loss of prescription drugs
Type: Introduction Status: Committee
Committee: Committee on Health
On agenda: 3/7/2024
Enactment date: Law number:
Title: A Local Law in relation to the development by the commissioner of health and mental hygiene of materials on the consequences of off-label use for weight loss of prescription drugs
Sponsors: Julie Menin, Lynn C. Schulman, James F. Gennaro, Farah N. Louis, Sandra Ung
Council Member Sponsors: 5
Summary: This bill would require the Commissioner of Health and Mental Hygiene to develop written materials containing information about the potential negative consequences of prescribing and using prescription drugs for off-label use for weight loss, including but not limited to medical side effects and reductions in drug supply. The materials would have to include a statement encouraging hospitals to share the materials with patients. The Commissioner would be required to post the materials on the website of the Department of Health and Mental Hygiene. The Commissioner would also have to provide the materials to hospitals unaffiliated with New York City for distribution to patients at the hospitals’ discretion. Additionally, the Commissioner would be required to provide the materials to hospitals under the New York City Health and Hospitals Corporation (NYC Health + Hospitals) for distribution to patients at the discretion of NYC Health + Hospitals.
Attachments: 1. Summary of Int. No. 620, 2. Int. No. 620, 3. March 7, 2024 - Stated Meeting Agenda, 4. Hearing Transcript - Stated Meeting 3-7-24

Int. No. 620

 

By Council Members Menin, Schulman, Gennaro, Louis and Ung

 

A Local Law in relation to the development by the commissioner of health and mental hygiene of materials on the consequences of off-label use for weight loss of prescription drugs

 

Be it enacted by the Council as follows:

 

Section 1. a. Definitions. As used in this section, the following terms have the following meanings:

Off-label use. The term “off-label use” means the use of a prescription drug in a manner that is not approved by the federal food and drug administration.

Prescription drug. The term “prescription drug” means any drug that under federal law can be dispensed only with a physician’s prescription.

b. Materials on the consequences of off-label use for weight loss of prescription drugs. No later than 90 days after the effective date of this local law, the commissioner of health and mental hygiene shall develop written materials containing information about the potential negative consequences of prescribing and using prescription drugs for off-label use for weight loss, including but not limited to the medical side effects of such use and reductions in the supply of such prescription drugs. The commissioner shall include a statement in such materials encouraging hospitals to share such materials with their patients.

c. Publication and distribution. 1. No later than 15 days after developing materials in compliance with subdivision b of this section, the commissioner shall post such materials on the website of the department of health and mental hygiene.

2. No later than 60 days after developing such materials, the commissioner shall provide such materials to hospitals that are not affiliated with the city that provide healthcare services in the city for distribution to patients at the discretion of such hospitals.

3. No later than 60 days after developing such materials, the commissioner shall provide such materials to hospitals operated by the New York city health and hospitals corporation for distribution to patients at the discretion of the New York city health and hospitals corporation.

§ 2. This local law takes effect immediately.

APM

LS #12569

3/1/2024 12:57 PM